CY22/23e EPS up 19/23% on robust outlook; TP raised to `2,110; ‘Buy’ maintained
Consolidated order book stands at a strong ~ Rs 650 billion.
With new launches, management expects to recover the market share; hence, operating leverage will also support EBITDA margin.
Volumes likely to remain in check; risk-reward priced in; Hold retained with TP of Rs 240.
Firm is net cash positive; FY22/23e Ebitda up 11/7%; TP up to Rs 347; ‘Buy’ retained
FY22/23e Ebitda up 10/7%; TP raised to Rs 3,065 from Rs 2,867; ‘Buy’ maintained.
Revival still some time away; TP raised to Rs 44 from Rs 42; ‘Hold’ rating maintained
Overdue receivables back in shape; new energy efforts promising; ‘Buy’ retained with TP of Rs 175; top pick
FY22/23/24e EPS raised by 56/49/33%; TP up to Rs 615; ‘Buy’ rating maintained
Equity sanctity has increased; ‘Buy’ retained with TP of Rs 1,000; a quality banking pick
9MFY22 growth robust; retail term likely to pick up; Q4 should be strong; ‘Buy’ retained with TP of Rs 870
Sales trajectory is likely to improve; launches key; ‘Buy’ retained with TP of Rs 592
Business mix was impacted again; given recovery pace, FY22e Ebitda down 3%; TP revised to Rs 3,966; ‘Reduce’ retained given…
Rural slowdown is likely to impact all FMCG companies in Q3FY22.
Impressive performance sustains: Coal India (CIL) sustained its robust operating performance in Dec-21. Key points: i) Production rate improves to…
India biz has slowed while international did well; ‘Hold’ retained with TP of Rs 580
Cineline re-entry as exhibitor to affect PVR’s Ebitda by just 2%; ‘Buy’ rating retained
Demand trends are strong; 22% EPS CAGR estimated over FY21-24e; ‘Buy’ rating retained with TP of Rs 1,000
